Pathstone Holdings’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$713K Buy
34,728
+1,871
+6% +$42.8K ﹤0.01% 1685
2026
Q1
$724K Buy
32,857
+1,231
+4% +$21.4K ﹤0.01% 1570
2025
Q4
$373K Sell
31,626
-3,965
-11% -$50.9K ﹤0.01% 1868
2025
Q3
$564K Buy
35,591
+15,526
+77% +$225K ﹤0.01% 1706
2025
Q2
$230K Buy
20,065
+1,393
+7% +$15.7K ﹤0.01% 2018
2025
Q1
$253K Sell
18,672
-8,608
-32% -$143K ﹤0.01% 1982
2024
Q4
$461K Buy
27,280
+242
+0.9% +$4.71K ﹤0.01% 1758
2024
Q3
$549K Sell
27,038
-1,806
-6% -$36.9K ﹤0.01% 1674
2024
Q2
$651K Buy
28,844
+950
+3% +$24.9K ﹤0.01% 1556
2024
Q1
$732K Buy
27,894
+2,545
+10% +$72.5K ﹤0.01% 1484
2023
Q4
$799K Buy
+25,349
New +$688K ﹤0.01% 1200

Other funds holding CC

Pathstone Holdings's CC Position: Q2 2026 in Review

Pathstone Holdings increased its Chemours (CC) stake by 5.7% in Q2 2026, buying an estimated $42.8K and bringing the position to 34,728 shares worth $713K. The position accounts for ﹤0.01% of the portfolio, ranked #1685.

Pathstone Holdings first reported a position in CC in Q4 2023 and has held it in 11 quarters since. The position peaked at $799K in Q4 2023. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Pathstone Holdings held 34,728 shares of Chemours worth $713K as of Q2 2026.
  • Pathstone Holdings bought 1,871 Chemours shares in Q2 2026, an estimated $42.8K.
  • Chemours made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1685 holding.
  • Pathstone Holdings first reported a position in Chemours in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Chemours position peaked at $799K in Q4 2023.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.